Xin Hou Selected Research

Granuloma

1/2019	B1 cells protect against Schistosoma japonicum-induced liver inflammation and fibrosis by controlling monocyte infiltration.
7/2015	Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica.
1/2014	A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice.
3/2013	A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicum.
2/2012	Polyinosinic-polycytidylic acid attenuates hepatic fibrosis in C57BL/6 mice with Schistosoma japonicum infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Hou Research Topics

Disease

24	Neoplasms (Cancer) 12/2023 - 10/2003
18	Inflammation (Inflammations) 05/2024 - 10/2003
10	Premature Birth (Birth, Premature) 03/2023 - 07/2015
10	Infections 12/2020 - 06/2012
8	Fibrosis (Cirrhosis) 09/2023 - 02/2012
6	Premature Obstetric Labor (Premature Labor) 01/2023 - 12/2002
5	Wounds and Injuries (Trauma) 09/2023 - 01/2020
5	COVID-19 01/2021 - 11/2020
5	Granuloma 01/2019 - 02/2012
5	Hepatocellular Carcinoma (Hepatoma) 06/2016 - 10/2003
4	Invasive Candidiasis 11/2023 - 01/2017
4	Ischemia 01/2022 - 02/2014
3	Osteoporosis 01/2022 - 02/2019
3	Graves Disease (Basedow Disease) 01/2022 - 12/2011
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020 - 01/2018
3	Hypothyroidism 01/2020 - 02/2011
3	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2017 - 06/2011
3	Retinal Neovascularization 01/2016 - 04/2006
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2015 - 01/2012
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2014 - 05/2008
2	Chronic Hepatitis B 05/2024 - 08/2022
2	Endometrial Neoplasms (Endometrial Cancer) 01/2024 - 04/2023
2	Hemorrhage 12/2023 - 07/2022
2	Tics (Tic) 01/2023 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2015
2	Infarction (Infarctions) 01/2022 - 02/2014
2	Hypoxia (Hypoxemia) 01/2021 - 02/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2013
2	Clostridium Infections 07/2020 - 01/2015
2	Rheumatoid Arthritis 01/2019 - 11/2014
2	Thyroid Diseases (Thyroid Disease) 01/2017 - 06/2011
2	Schistosomiasis (Bilharziasis) 07/2015 - 01/2014
2	Schistosomiasis japonica 07/2015 - 02/2012
2	Massive Hepatic Necrosis 02/2015 - 03/2009
2	Brain Injuries (Brain Injury) 02/2014 - 10/2008
2	Hypercapnia 06/2010 - 05/2002
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 04/2003 - 03/2003
1	Intracranial Embolism 05/2024

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2002
6	AntibodiesIBA 01/2021 - 10/2003
6	CytokinesIBA 01/2021 - 06/2012
6	Peptides (Polypeptides)IBA 01/2021 - 10/2008
5	Immune Checkpoint InhibitorsIBA 12/2023 - 03/2022
5	ProstaglandinsIBA 03/2023 - 05/2002
5	Interleukin-1 (Interleukin 1)IBA 01/2023 - 10/2008
4	Tocolytic Agents (Tocolytics)IBA 03/2023 - 09/2011
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023 - 10/2008
4	Biomarkers (Surrogate Marker)IBA 03/2022 - 02/2015
4	Retinaldehyde (Retinal)IBA 04/2020 - 05/2002
4	Interleukin-10 (Interleukin 10)IBA 01/2019 - 02/2012
3	LipopolysaccharidesIBA 01/2024 - 01/2019
3	EchinocandinsIBA 11/2023 - 01/2018
3	EnzymesIBA 10/2023 - 08/2020
3	HydrogelsIBA 09/2023 - 07/2022
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
3	Therapeutic UsesIBA 01/2023 - 01/2017
3	LipidsIBA 01/2022 - 02/2011
3	Immunoglobulin G (IgG)IBA 01/2021 - 12/2020
3	Immunoglobulin M (IgM)IBA 01/2021 - 12/2020
3	Amino Acids FDA Link 12/2020 - 09/2011
3	NanocapsulesIBA 09/2020 - 05/2018
3	corticosteroid hormone-induced factorIBA 01/2020 - 01/2018
3	ChemokinesIBA 10/2019 - 06/2012
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 10/2008
3	AzolesIBA 01/2018 - 01/2017
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 05/2013
3	Poly I-CIBA 02/2012 - 03/2009
2	Hemostatics (Antihemorrhagics)IBA 12/2023 - 07/2022
2	AntigensIBA 11/2023 - 03/2013
2	101.10 peptideIBA 01/2023 - 10/2008
2	oxidized low density lipoproteinIBA 06/2022 - 02/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2017
2	TRPC6 Cation ChannelIBA 01/2021 - 01/2020
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 03/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2019
2	ProteomeIBA 01/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	Polysaccharides (Glycans)IBA 10/2019 - 02/2019
2	Messenger RNA (mRNA)IBA 10/2019 - 02/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2019 - 07/2015
2	Alanine Transaminase (SGPT)IBA 01/2019 - 03/2013
2	CollagenIBA 01/2019 - 07/2015
2	EndotoxinsIBA 01/2017 - 12/2002
2	LigandsIBA 09/2016 - 10/2015
2	platelet activating factor receptorIBA 01/2016 - 01/2016
2	AutoantibodiesIBA 10/2015 - 12/2011
2	Interleukin-17 (Interleukin 17)IBA 07/2015 - 06/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 04/2006
2	GalactosamineIBA 02/2015 - 03/2009
2	Interleukin-12 (IL 12)IBA 11/2014 - 02/2012
2	boswellic acidIBA 01/2014 - 03/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 09/2010
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2011 - 01/2011
1	Nerve Growth Factors (Neurotrophins)IBA 05/2024
1	fibrin fragment D (D-dimer)IBA 05/2024
1	OxidesIBA 05/2024

Therapy/Procedure

20	Therapeutics 09/2023 - 01/2006
4	Immunotherapy 04/2023 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2014
2	Lasers (Laser) 01/2023 - 01/2022